A State Department plan scheduled to be implemented June 1 would strip the U.S. of decades of disease defense, write eight ...

Women and girls in eastern Congo will be harmed in predictable, named ways over the next 12 months,” write researchers ...

Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost ...

President Trump had another medical exam on Tuesday, putting his health under renewed public scrutiny after he has worked to ...

Just because a company invests does not mean it has invented anything novel,” Tahir Amin and Rohit Malpani write in this ...

People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney ...

CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics ...

The Trump administration disclosed plans to reduce state directed payments even more, setting up a probable showdown with ...

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

The company behind the analytics, Vizient, touts MGH's increasing hospice enrollment to improved mortality performance.